Last reviewed · How we verify
NCT05150145
Radiotherapy or Observation of Liver Metastases in Small Cell Lung Cancer
NA trial testing Radiotherpy will be performed to thoracic and liver metastasis after chemotherapy. in Radiotherapy; Complications in 66 participants. Currently enrolling.
1 March 2026
Quick facts
| Lead sponsor | Guizhou Medical University |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 66 |
| Start date | 30 April 2021 |
| Primary completion | 1 March 2026 |
| Estimated completion | 1 March 2026 |
| Sites | 1 location across China |
Drugs / interventions tested
- Radiotherpy will be performed to thoracic and liver metastasis after chemotherapy.
Conditions studied
- Radiotherapy; Complications — all drugs for Radiotherapy; Complications →
Sponsor
Guizhou Medical University
Who can join
Adults 18 to 70, any sex, with Radiotherapy; Complications. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this randomized study is to investigate local tumor control,survival outcomes and complications on patients of liver metastasis in small cell lung cancer.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05150145
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Radiotherapy; Complications
Currently open trials in the same condition.
- NCT06180434 — Short Term Outcomes After PRoton and PhotoN RadiOtherapy for IDH Mutated Grade 2 and 3 Gliomas · recruiting
- NCT06405217 — Recombinant Human Thyroid Stimulating Hormone for Radioiodine 131I Treatment · NA · recruiting
- NCT06418113 — Neoadjuvant Radio-chemotherapy Safety Pilot Study in Patients With Glioblastoma · Phase 1 · recruiting
- NCT06313450 — De-escalated Radiotherapy for Primary Tumor After Neoadjuvant Therapy With Toripalimab Plus Chemotherapy for Nasopharyng · NA · recruiting
- NCT06051240 — Lithium Treatment to Prevent Cognitive Impairment After Brain Radiotherapy · Phase 2 · recruiting
Other Guizhou Medical University trials
Trials by the same sponsor.
- NCT07462728 — Phase III, Multicenter, Randomized Controlled Clinical Study of Three-Dimensional Radiotherapy for Primary Tumors in Non · NA · not yet recruiting
- NCT07025863 — Intervention Program for Alarm Fatigue in NICU Nurses Based on ABC-X Model · NA · enrolling by invitation
- NCT06014450 — Prophylactic Cranial Irradiation Versus Observation in Stage IV NSCLC Randomized Controlled Clinical Study · NA · unknown
- NCT05252065 — Cardiac Substructure Radiation Dose and Early Clinical Monitoring of Stage N2-3 Non-Small Cell Lung Cancer · unknown
- NCT05176067 — Randomized Controlled Clinical Study of Drug Therapy Combined With Thoracic Radiotherapy for Non-oligometastatic NSCLC · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05150145 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Guizhou Medical University
- Last refreshed: 26 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05150145.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing